ArticleCerebellum (London, England)2026

N140 Latency as a Novel Biomarker for the Evaluation of Somatosensory Dysfunction in Patients with Spinocerebellar Ataxia Type 2.

Joel Gutiérrez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.